NeOnc Technologies Holdings Inc. (NTHI)
NTHI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.60
-4.95% on the day
Market cap
$77.2M
Micro cap
Revenue · 2025
$40K
-51.8% on 2024
Net income · 2025
-$62.1M
-155404.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NTHI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001979414 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $40K |
| Net income | -$62.1M |
| Operating income | -$58.2M |
| Net margin | -155404.4% |
| Operating margin | -145637.5% |
| Revenue growth | -51.8% |
| Cash | $59K |
| Total assets | $2.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1931.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-10 |
| Latest annual report | 10-K/A | 2026-05-05 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-09-28 |
| Latest proxy | DEFA14A | 2026-06-23 |
Source: SEC EDGAR submissions feed, 202 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RFL | Rafael Holdings Inc. | $1.49 | -1.97% | $77.5M |
| PMN | ProMIS Neurosciences Inc. Common Shares (ON) | $8.66 | -8.36% | $77.7M |
| INCR | Intercure Ltd. | $5.03 | +1.62% | $75.5M |
| ACRV | Acrivon Therapeutics Inc. | $1.75 | -7.89% | $75.0M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
| TELO | Telomir Pharmaceuticals Inc. | $1.09 | -0.91% | $80.2M |
| HRTX | Heron Therapeutics Inc. | $0.3906 | -6.01% | $74.2M |
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier